These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38531102)

  • 41. Malaria Vaccines: Recent Advances and New Horizons.
    Draper SJ; Sack BK; King CR; Nielsen CM; Rayner JC; Higgins MK; Long CA; Seder RA
    Cell Host Microbe; 2018 Jul; 24(1):43-56. PubMed ID: 30001524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
    White M; Amino R; Mueller I
    Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of
    James ER; Matheny S; Overby J; Sim BKL; Eappen AG; Li T; Li ML; Richie TL; Chakravarty S; Gunasekera A; Murshedkar T; Billingsley PF; Hoffman SL
    Front Immunol; 2022; 13():851028. PubMed ID: 35242146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
    Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
    Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.
    Arévalo-Herrera M; Vásquez-Jiménez JM; Lopez-Perez M; Vallejo AF; Amado-Garavito AB; Céspedes N; Castellanos A; Molina K; Trejos J; Oñate J; Epstein JE; Richie TL; Herrera S
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005070. PubMed ID: 27760143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines against malaria: perspectives from Papua New Guinea.
    Mueller I; Genton B; Betuela I; Alpers MP
    Hum Vaccin; 2010 Jan; 6(1):17-20. PubMed ID: 20173407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.
    Shekalaghe S; Rutaihwa M; Billingsley PF; Chemba M; Daubenberger CA; James ER; Mpina M; Ali Juma O; Schindler T; Huber E; Gunasekera A; Manoj A; Simon B; Saverino E; Church LWP; Hermsen CC; Sauerwein RW; Plowe C; Venkatesan M; Sasi P; Lweno O; Mutani P; Hamad A; Mohammed A; Urassa A; Mzee T; Padilla D; Ruben A; Sim BKL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2014 Sep; 91(3):471-480. PubMed ID: 25070995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
    Bettencourt P
    Front Immunol; 2020; 11():190. PubMed ID: 32153565
    [No Abstract]   [Full Text] [Related]  

  • 50. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.
    Goswami D; Patel H; Betz W; Armstrong J; Camargo N; Patil A; Chakravarty S; Murphy SC; Sim BKL; Vaughan AM; Hoffman SL; Kappe SH
    EMBO Mol Med; 2024 Apr; 16(4):723-754. PubMed ID: 38514791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines.
    Vannice KS; Brown GV; Akanmori BD; Moorthy VS
    Malar J; 2012 Nov; 11():372. PubMed ID: 23140365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
    Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
    Front Immunol; 2021; 12():625712. PubMed ID: 33815377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of transgenic parasites in malaria vaccine research.
    Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetically engineered, attenuated whole-cell vaccine approaches for malaria.
    Vaughan AM; Wang R; Kappe SH
    Hum Vaccin; 2010 Jan; 6(1):107-13. PubMed ID: 19838068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.
    Epstein JE; Tewari K; Lyke KE; Sim BK; Billingsley PF; Laurens MB; Gunasekera A; Chakravarty S; James ER; Sedegah M; Richman A; Velmurugan S; Reyes S; Li M; Tucker K; Ahumada A; Ruben AJ; Li T; Stafford R; Eappen AG; Tamminga C; Bennett JW; Ockenhouse CF; Murphy JR; Komisar J; Thomas N; Loyevsky M; Birkett A; Plowe CV; Loucq C; Edelman R; Richie TL; Seder RA; Hoffman SL
    Science; 2011 Oct; 334(6055):475-80. PubMed ID: 21903775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.
    Duffy PE
    Expert Rev Vaccines; 2021 Feb; 20(2):185-198. PubMed ID: 33478283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malaria Vaccines: Progress to Date.
    Stanisic DI; Good MF
    BioDrugs; 2023 Nov; 37(6):737-756. PubMed ID: 37728713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination With Sporozoites: Models and Correlates of Protection.
    Goh YS; McGuire D; Rénia L
    Front Immunol; 2019; 10():1227. PubMed ID: 31231377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
    Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
    Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.
    Jongo S; Church LWP; Milando F; Qassim M; Schindler T; Rashid M; Tumbo A; Nyaulingo G; Bakari BM; Athuman Mbaga T; Mohamed L; Kassimu K; Simon BS; Mpina M; Zaidi I; Duffy PE; Swanson PA; Seder R; Herman JD; Mendu M; Zur Y; Alter G; Kc N; Riyahi P; Abebe Y; Murshedkar T; James ER; Billingsley PF; Sim BKL; Richie TL; Daubenberger C; Abdulla S; Hoffman SL
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38194272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.